PCOS Is Now Officially Renamed PMOS – What Women in Dubai Need to Know

PCOS Is Now Officially Renamed PMOS – What Women in Dubai Need to Know

---

After a decade of global research involving 22,000 experts, PCOS has been officially renamed PMOS – Polyendocrine Metabolic Ovarian Syndrome – in a landmark paper published in The Lancet on May 12, 2026. Here is everything you need to know about what this means for symptoms, fertility, and specialist care in the UAE.
PMOS (Polyendocrine Metabolic Ovarian Syndrome) is the official new name for PCOS, confirmed in a landmark global consensus published in The Lancet on May 12, 2026 – the result of an 11-year process involving 22,000 clinicians, researchers, and patients worldwide. The name change is now endorsed by 56 major academic and patient organisations globally. PMOS affects 1 in 8 women (170 million worldwide). In Dubai, specialist fertility clinics offer comprehensive PMOS diagnosis, hormonal management, and advanced fertility treatments, including IUI and IVF.

It’s Official: PCOS Has Been Renamed PMOS

What was previously discussed as an emerging terminology shift is now confirmed science. On May 12, 2026, the international medical community formally retired the name PCOS and replaced it with PMOS – Polyendocrine Metabolic Ovarian Syndrome – through a rigorous, decade-long global consensus process led by Professor Helena Teede at Monash University, Australia.

Lancet Citation Box

Published in The Lancet – May 12, 2026
“Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process” – simultaneously presented at the European Congress of Endocrinology in Prague.

Reference: Teede HJ, Bahri Khomami M, Morman R, et al. The Lancet. Published online May 12, 2026. doi:10.1016/S0140-6736(26)00717-8

Over 11 years, approximately 22,000 stakeholders – including doctors, researchers, patients, and patient advocacy groups from around the world – contributed to shaping the new name. PMOS was the near-unanimous winner, chosen over two other finalists: Endocrine Metabolic Ovulatory Syndrome and Ovulatory Metabolic Endocrine Syndrome.

The new name is now endorsed by over 56 leading academic, clinical, and patient organisations globally, and a rollout plan spanning 195 countries over 3 years has been put into motion – covering updates to clinical guidelines, medical education curricula, and international disease classification systems (including ICD codes).

Key Facts from the Official Name Change

• Confirmed in The Lancet, May 12, 2026 – one of medicine’s most authoritative journals
• Led by Monash University (Australia) via the International PCOS Network
• 22,000 global stakeholders consulted across three surveys (2017, 2023, 2025)
• 56 major academic, clinical and patient organisations have endorsed the change
• PMOS affects 1 in 8 women – 170 million people worldwide
• 3-year global rollout underway across 195 countries’ clinical guidelines
• ICD disease classification codes will be updated to reflect PMOS

For women in Dubai and the UAE currently living with a PCOS diagnosis, this change has immediate practical meaning: your existing diagnosis remains fully valid, and your care pathway does not change overnight. What the renaming does is signal that clinicians will increasingly approach the condition through a broader hormonal and metabolic lens – which is better for your long-term health outcomes.

What Is PMOS? Understanding the Updated Diagnosis

PMOS – Polyendocrine Metabolic Ovarian Syndrome – is the contemporary, more accurate term for the condition most people know as PCOS (Polycystic Ovary Syndrome). The terminology shift is being driven by leading reproductive medicine researchers and endocrinologists who argued the original name was misleading and incomplete.

Breaking the acronym down: “polyendocrine” refers to the involvement of multiple hormone-secreting glands, and “metabolic” emphasises the condition’s deep connection to insulin function, blood sugar regulation, and body weight. The result is a name that more honestly describes what patients and clinicians are actually dealing with.

What PMOS Literally Means

• Poly – Many/ multiple systems affected
• Endocrine – Involving hormone-producing glands (pituitary, adrenal, thyroid, ovaries)
• Metabolic – Connected to insulin resistance, blood sugar & weight regulation
• Ovarian – Originating in or significantly affecting the ovaries
• Syndrome – A cluster of co-occurring signs and symptoms

Why Was PCOS Renamed to PMOS?

The push to replace PCOS with PMOS had been growing within the reproductive medicine community for years – and in May 2026, it became official. The core problem the rename addresses: the original name was built around a specific anatomical finding – polycystic ovaries – that is neither present in every patient nor the defining feature of the disorder.

PCOS (Old Term) vs PMOS (Updated Term)

PCOS focused on:

• Cysts in the ovaries – not present in all patients
• Implied all patients have ovarian cysts
• Overlooked insulin resistance as a core driver
• Led to over-focus on ovarian treatment alone
• Caused diagnostic confusion and delays in up to 70% of cases

PMOS reflects:

• Whole-body hormonal and metabolic impact
• Accommodates patients without cysts
• Highlights metabolic dysfunction explicitly
• Encourages comprehensive, multi-system management
• Supports earlier, more accurate diagnosis

Research confirms that only around 75% of women diagnosed under PCOS criteria actually show polycystic-appearing ovaries on ultrasound. The remaining patients may carry the diagnosis for years without their full hormonal picture being addressed. The PMOS nomenclature is designed to close that gap.

Key Statistics

• 1 in 8 women of reproductive age affected by PMOS – 170 million worldwide (The Lancet, 2026)
• 70% of women with PMOS have some degree of insulin resistance
• 70% of cases were previously undiagnosed or delayed – the PMOS rename aims to close this gap

Common Symptoms of PMOS

Because PMOS affects the interplay between the endocrine system and metabolic function, its symptoms span multiple body systems. This is precisely why many women spend years searching for answers – the condition may be mistaken for thyroid disorders, depression, or simple weight issues.

• Irregular or absent menstrual periods – cycles that are infrequent or unpredictable
• Weight gain – difficulty losing weight despite diet and exercise
• Insulin resistance – elevated blood sugar, cravings, and energy crashes
• Excess hair growth (hirsutism) – unwanted facial, chest, or stomach hair
• Acne and oily skin – often driven by elevated androgen hormones
• Hair thinning – scalp hair loss (androgenic alopecia)
• Fatigue – persistent low energy linked to insulin and cortisol disruption
• Mood changes – anxiety, low mood, or depression due to hormonal fluctuations
• Fertility challenges – difficulty conceiving due to irregular or absent ovulation
• Darkened skin patches (acanthosis nigricans) – around the neck or underarms

Note: If you experience three or more of the above signs – especially in combination with irregular periods – speak to a fertility or endocrine specialist in Dubai.

PMOS and Insulin Resistance: A Key Metabolic Link

One of the strongest reasons for the terminology shift to PMOS is insulin resistance – a metabolic dysfunction affecting up to 70% of women with the condition. Insulin resistance occurs when cells in the body fail to respond normally to insulin, causing the pancreas to produce more to compensate.

In the context of PMOS, excess insulin directly stimulates the ovaries to produce additional androgens (male hormones), which disrupts the follicular development needed for regular ovulation. The downstream effects include:

• Elevated testosterone and DHEA-S – fuelling acne, excess hair, and hair loss
• Disrupted LH/FSH ratio – preventing mature egg release
• Chronic low-grade inflammation – compounding metabolic and reproductive dysfunction
• Increased long-term risk – Type 2 diabetes, cardiovascular disease, endometrial issues

Recognizing insulin resistance as a central driver – not a side effect – is why PMOS treatment now increasingly includes metabolic interventions alongside traditional hormonal therapies.

How PMOS Affects Fertility and Conception

Fertility challenges are among the most distressing aspects of PMOS for many women in Dubai and across the UAE. The condition can affect conception at several stages of the reproductive cycle.

The most common fertility-related effects of PMOS include:

• Irregular or absent ovulation (anovulation)
• Poor follicular development
• Imbalanced LH/FSH hormone ratios
• Elevated risk of early miscarriage
• Difficulty maintaining a healthy pregnancy in some cases

However, a PMOS diagnosis is not a verdict against motherhood. With the correct clinical approach, a significant proportion of women with PMOS successfully conceive – both naturally after lifestyle intervention and with structured fertility treatment. Success rates improve considerably with early diagnosis and a personalized care plan.

Fertility Treatments Available for PMOS in Dubai

• Ovulation induction with oral medications (e.g. letrozole, clomiphene)
• Injectable gonadotropins for controlled ovarian stimulation
• Intrauterine Insemination (IUI) – combined with ovulation tracking
• In Vitro Fertilisation (IVF) – for complex or long-standing infertility
• Cycle monitoring with ultrasound and hormone panels
• Egg quality support through nutritional and antioxidant protocols

How PMOS Is Diagnosed in Dubai

Accurate diagnosis of PMOS requires a thorough clinical evaluation. Because its symptoms overlap with thyroid disorders, hyperprolactinaemia, and adrenal conditions, specialist assessment is essential. In Dubai, leading fertility clinics follow evidence-based diagnostic protocols:

• Clinical History & Symptom Review – Detailed menstrual history, symptom timeline, BMI, and family history of hormonal disorders.
• Hormone Blood Panel – LH, FSH, AMH, testosterone, DHEA-S, SHBG, oestradiol, prolactin, and thyroid function (TSH, fT4).
• Fasting Glucose & Insulin Testing – Fasting insulin, glucose, HbA1c, and HOMA-IR score to assess insulin resistance severity.
• Pelvic Ultrasound – Antral follicle count and ovarian volume assessment; AMH levels cross-referenced.
• Metabolic & Cardiovascular Screening – Lipid profile, blood pressure, and body composition assessment for comprehensive risk evaluation.

PMOS Treatment Options: A Comprehensive Approach

Effective PMOS treatment in Dubai combines hormonal, metabolic, and reproductive interventions tailored to each patient’s specific profile, age, and fertility goals. There is no single protocol – personalization is key.

1. Lifestyle & Nutrition Therapy

Structured weight management, low-glycaemic dietary plans, and exercise programmes. Even 5-10% weight loss can restore ovulation in many women.

2. Insulin-Sensitising Medication

Metformin and newer agents help the body respond to insulin more effectively, reducing androgen levels and improving cycle regularity.

3. Hormonal Regulation

Tailored hormonal therapies to regulate menstrual cycles, reduce excess androgens, and address acne and hirsutism.

4. Ovulation Induction

Oral and injectable medications to stimulate regular follicle development and egg release, closely monitored by ultrasound.

5. IUI Treatment

Intrauterine insemination combined with ovulation induction for couples with PMOS-related fertility challenges.

6. IVF Treatment

Advanced IVF with tailored stimulation protocols designed to reduce the risk of ovarian hyperstimulation in PMOS patients.

PMOS and Emotional Wellbeing

The hormonal fluctuations, physical symptoms, and fertility challenges of PMOS carry a significant emotional weight. Studies indicate that women with PMOS experience higher rates of anxiety, depression, and body image concerns compared to the general population.

Comprehensive PMOS care in Dubai recognises psychological wellbeing as integral to treatment. Evidence-based approaches include:

• Cognitive Behavioural Therapy (CBT) for anxiety and low mood related to fertility stress
• Peer support groups and fertility counselling
• Mindfulness-based stress reduction
• Hormonal treatment that addresses mood-disrupting androgen excess

Women going through PMOS treatment should know that emotional responses to this diagnosis are valid, and that seeking psychological support is a recognised and recommended part of the clinical pathway.

Long-Term Health Risks of Untreated PMOS

One of the strongest arguments for adopting the PMOS framework is its power to improve long-term health outcomes. When the condition is understood only as an ovarian issue, important systemic risks are easily overlooked. Left unmanaged, PMOS carries elevated risks including:

• Type 2 diabetes – due to chronic insulin resistance
• Cardiovascular disease and hypertension
• Non-alcoholic fatty liver disease (NAFLD)
• Endometrial hyperplasia due to absent ovulation
• Sleep apnoea – especially in women with central weight gain
• Elevated lifetime risk of metabolic syndrome

Early diagnosis, lifestyle modification, and appropriate medical management significantly reduce these long-term risks – making specialist evaluation in your reproductive years one of the most important investments in long-term health.

Frequently Asked Questions About PMOS

Conclusion

PMOS – Polyendocrine Metabolic Ovarian Syndrome – is no longer just an emerging term. As of May 12, 2026, it is the official name for the condition affecting 1 in 8 women worldwide, confirmed by a global scientific consensus published in The Lancet. The rename marks a turning point in how this complex, multi-system hormonal condition is understood, diagnosed, and treated.

For women in Dubai and the UAE, this means access to more accurate diagnosis, more targeted treatment, and better long-term health outcomes. Whether you are managing symptoms, planning a pregnancy, or seeking specialist care, early intervention remains the most powerful tool available.

Orchid Fertility Clinic provides advanced PMOS assessment, hormone evaluation, IVF support, and personalized fertility treatment for women seeking expert reproductive care in Dubai and the UAE. Our experienced fertility specialists support women through every step of their hormonal wellness journey.

Medically reviewed by: Dr. Partha Das, Consultant Reproductive Medicine and Infertility
Medical review date: 22nd July 2026
Medical Disclaimer
The information provided in this article is for general educational and informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Fertility and IVF outcomes vary between individuals and depend on a range of medical and personal factors. The information provided does not guarantee any particular treatment outcome or pregnancy result.